Scientists are calling for stage 3 clinical trials of an Alzheimer’s drug to be scrapped after a report highlighted serious doubts about the legitimacy of research that helped the medicine reach that stage.
A long-awaited report by the City University of New York (CUNY) accused one of its faculty members, neuroscientist Hoau-Yan Wang, of egregious misconduct concerning 20 research papers — defined as workplace behavior so outrageous, dangerous, or illegal that an employer cannot reasonably expect to correct it through progressive discipline.
Wang is being rightly excoriated while others have wrongly received awards for ‘courage’ for their covid anti-science. ABN